Abstract

Large disulfide-stabilized proteoglycan complexes were previously shown to be synthesized by the epidermis of axolotl embryos during stages crucial to subepidermal migration of neural crest cells. We now show that the complexes contain PG-M/versican-like monomers in addition to some other component with low buoyant density. Metabolically 35S-labeled proteoglycans were extracted from epidermal explants and separated by size exclusion chromatography and density equilibrium gradient centrifugation. The complexes, which elute in the void volume on Sepharose CL-2B, were recovered at buoyant density 1.42 g/ml in CsCl gradients, whereas the monomer proteoglycans, which could only be liberated from the complexes by reduction, had a higher buoyant density (1.48 g/ml). The native complexes did not aggregate with hyaluronan. The purified complexes reacted with antibodies against a portion of a cloned PG-M/versican-like axolotl proteoglycan. These antibodies were found to stain the subepidermal matrix of axolotl embryos, suggesting that the proteoglycan complexes are encountered by neural crest cells during subepidermal migration. From Western blot analysis, the core protein of the PG-M/versican-like monomers was found to be of similar size ( approximately 500 kDa) as those of PG-M/versican variants of other species. Another chondroitin sulfate proteoglycan that was present in small amounts in the epidermal extracts was found to be distinctly different from the similarly sized PG-M/versican-like monomers.

Highlights

  • The role of proteoglycans (PGs)1 in the modulation of cellmatrix interaction and cell migration depends on their structure and localization [1,2,3]

  • We show that the complexes contain PG-M/versican-like monomers in addition to some other component with low buoyant density

  • We report that the complexes contain PG-M/versican-like PG monomers in addition to some other component of low buoyant density

Read more

Summary

EXPERIMENTAL PROCEDURES

After incubation for 20 h at 20 °C, corresponding to the time between stages 30 to 35 (as determined by the parallel incubation of control embryos), the labeling medium was removed and the tissue was dissolved in extraction buffer (about 400 ␮l per 50 explants) containing 4 M guanidine HCl, 50 mM sodium acetate, pH 5.8, and 0.2% Triton X-100, together with 1 mM N-ethylmaleimide (NEM), 100 mM ⑀-aminocaproic acid, 10 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride as protease inhibitors [35]. To test the effectiveness and specificity of the collagenase treatment, collagen and fibronectin (kindly provided by Dr Staffan Johansson, Department of Medical Chemistry, Uppsala University) were treated in parallel under identical conditions as positive and negative controls, respectively, and analyzed by SDS-PAGE. After ligation of the polymerase chain reaction product into pGEX-3 and

RESULTS
The HMPG Monomers Are Distinctly Different from the IMPGs
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call